CPTR Stock Overview
Engages in the retail sale of cannabis products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Captor Capital Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.80 |
| 52 Week High | CA$5.01 |
| 52 Week Low | CA$0.23 |
| Beta | 0.36 |
| 11 Month Change | -31.03% |
| 3 Month Change | -65.96% |
| 1 Year Change | -51.52% |
| 33 Year Change | -95.40% |
| 5 Year Change | -81.61% |
| Change since IPO | -98.67% |
Recent News & Updates
Additional Considerations Required While Assessing Captor Capital's (CSE:CPTR) Strong Earnings
Sep 06
The Market Lifts Captor Capital Corp. (CSE:CPTR) Shares 189% But It Can Do More
Jul 30Captor Capital Corp. (CSE:CPTR) Stock Rockets 189% But Many Are Still Ignoring The Company
Jul 30Recent updates
Additional Considerations Required While Assessing Captor Capital's (CSE:CPTR) Strong Earnings
Sep 06The Market Lifts Captor Capital Corp. (CSE:CPTR) Shares 189% But It Can Do More
Jul 30Captor Capital Corp. (CSE:CPTR) Stock Rockets 189% But Many Are Still Ignoring The Company
Jul 30Here's Why We're Not Too Worried About Captor Capital's (CSE:CPTR) Cash Burn Situation
Feb 03Shareholder Returns
| CPTR | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -18.4% | 10.1% | 0.2% |
| 1Y | -51.5% | -19.0% | 21.0% |
Return vs Industry: CPTR underperformed the Canadian Pharmaceuticals industry which returned -19% over the past year.
Return vs Market: CPTR underperformed the Canadian Market which returned 21% over the past year.
Price Volatility
| CPTR volatility | |
|---|---|
| CPTR Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 11.8% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.5% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: CPTR's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine CPTR's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 78 | John Zorbas | captorcapital.com |
Captor Capital Corp. engages in the retail sale of cannabis products in the United States. The company was formerly known as NWT Uranium Corp. and changed its name to Captor Capital Corp. on June 2, 2017. Captor Capital Corp. was incorporated in 2003 and is based in Toronto, Canada.
Captor Capital Corp. Fundamentals Summary
| CPTR fundamental statistics | |
|---|---|
| Market cap | CA$2.78m |
| Earnings (TTM) | CA$19.36m |
| Revenue (TTM) | CA$58.70m |
0.1x
P/E Ratio0.0x
P/S RatioIs CPTR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CPTR income statement (TTM) | |
|---|---|
| Revenue | CA$58.70m |
| Cost of Revenue | CA$14.93m |
| Gross Profit | CA$43.77m |
| Other Expenses | CA$24.41m |
| Earnings | CA$19.36m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.57 |
| Gross Margin | 74.56% |
| Net Profit Margin | 32.98% |
| Debt/Equity Ratio | 0% |
How did CPTR perform over the long term?
See historical performance and comparison